115 related articles for article (PubMed ID: 37452741)
1. PABPN1 promotes clear cell renal cell carcinoma progression by suppressing the alternative polyadenylation of SGPL1 and CREG1.
Xiong M; Liu C; Li W; Jiang H; Long W; Zhou M; Yang C; Kazobinka G; Sun Y; Zhao J; Hou T
Carcinogenesis; 2023 Oct; 44(7):576-586. PubMed ID: 37452741
[TBL] [Abstract][Full Text] [Related]
2. Disruption of PABPN1 phase separation by SNRPD2 drives colorectal cancer cell proliferation and migration through promoting alternative polyadenylation of CTNNBIP1.
Hu Z; Li M; Chen Y; Chen L; Han Y; Chen C; Lu X; You N; Lou Y; Huang Y; Huo Z; Liu C; Liang C; Liu S; Deng K; Chen L; Chen S; Wan G; Wu X; Fu Y; Xu A
Sci China Life Sci; 2024 Jun; 67(6):1212-1225. PubMed ID: 38811444
[TBL] [Abstract][Full Text] [Related]
3. Alternative polyadenylation is associated with lower expression of PABPN1 and poor prognosis in non-small cell lung cancer.
Ichinose J; Watanabe K; Sano A; Nagase T; Nakajima J; Fukayama M; Yatomi Y; Ohishi N; Takai D
Cancer Sci; 2014 Sep; 105(9):1135-41. PubMed ID: 24975429
[TBL] [Abstract][Full Text] [Related]
4. Dysfunctional transcripts are formed by alternative polyadenylation in OPMD.
Raz V; Dickson G; 't Hoen PAC
Oncotarget; 2017 Sep; 8(43):73516-73528. PubMed ID: 29088723
[TBL] [Abstract][Full Text] [Related]
5. PABPN1 regulates mRNA alternative polyadenylation to inhibit bladder cancer progression.
Chen L; Dong W; Zhou M; Yang C; Xiong M; Kazobinka G; Chen Z; Xing Y; Hou T
Cell Biosci; 2023 Mar; 13(1):45. PubMed ID: 36879298
[TBL] [Abstract][Full Text] [Related]
6. Dissecting the heterogeneity of the alternative polyadenylation profiles in triple-negative breast cancers.
Wang L; Lang GT; Xue MZ; Yang L; Chen L; Yao L; Li XG; Wang P; Hu X; Shao ZM
Theranostics; 2020; 10(23):10531-10547. PubMed ID: 32929364
[No Abstract] [Full Text] [Related]
7. The poly(A)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sites.
Jenal M; Elkon R; Loayza-Puch F; van Haaften G; Kühn U; Menzies FM; Oude Vrielink JA; Bos AJ; Drost J; Rooijers K; Rubinsztein DC; Agami R
Cell; 2012 Apr; 149(3):538-53. PubMed ID: 22502866
[TBL] [Abstract][Full Text] [Related]
8. Suppressive effects of iron chelation in clear cell renal cell carcinoma and their dependency on VHL inactivation.
Greene CJ; Sharma NJ; Fiorica PN; Forrester E; Smith GJ; Gross KW; Kauffman EC
Free Radic Biol Med; 2019 Mar; 133():295-309. PubMed ID: 30553971
[TBL] [Abstract][Full Text] [Related]
9. CRISPR-Cas9 mediated generation of a conditional poly(A) binding protein nuclear 1 (Pabpn1) mouse model reveals an essential role for hematopoietic stem cells.
Sommerkamp P; Sommerkamp AC; Zeisberger P; Eiben PL; Narr A; Korkmaz A; Przybylla A; Sohn M; van der Hoeven F; Schönig K; Trumpp A
Sci Rep; 2022 May; 12(1):7181. PubMed ID: 35504940
[TBL] [Abstract][Full Text] [Related]
10. Poly(A) binding protein nuclear 1 levels affect alternative polyadenylation.
de Klerk E; Venema A; Anvar SY; Goeman JJ; Hu O; Trollet C; Dickson G; den Dunnen JT; van der Maarel SM; Raz V; 't Hoen PA
Nucleic Acids Res; 2012 Oct; 40(18):9089-101. PubMed ID: 22772983
[TBL] [Abstract][Full Text] [Related]
11. PABPN1 aggregation is driven by Ala expansion and poly(A)-RNA binding, leading to CFIm25 sequestration that impairs alternative polyadenylation.
Guan WL; Jiang LL; Yin XF; Hu HY
J Biol Chem; 2023 Aug; 299(8):105019. PubMed ID: 37422193
[TBL] [Abstract][Full Text] [Related]
12. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of alternative polyadenylation regulators of CTLA4 and immune infiltration in clear cell renal cell carcinoma.
Zhou M; Long W; Xiong M; Zhang F; Chen L; Chen J; Pang Z; Hou T; Li W
Transl Androl Urol; 2023 Apr; 12(4):533-548. PubMed ID: 37181233
[TBL] [Abstract][Full Text] [Related]
14. Polyadenylation-dependent control of long noncoding RNA expression by the poly(A)-binding protein nuclear 1.
Beaulieu YB; Kleinman CL; Landry-Voyer AM; Majewski J; Bachand F
PLoS Genet; 2012; 8(11):e1003078. PubMed ID: 23166521
[TBL] [Abstract][Full Text] [Related]
15. Alternative Polyadenylation Utilization Results in Ribosome Assembly and mRNA Translation Deficiencies in a Model for Muscle Aging.
Mei H; Boom J; El Abdellaoui S; Abdelmohsen K; Munk R; Martindale JL; Kloet S; Kielbasa SM; Sharp TH; Gorospe M; Raz V
J Gerontol A Biol Sci Med Sci; 2022 Jun; 77(6):1130-1140. PubMed ID: 35245938
[TBL] [Abstract][Full Text] [Related]
16. PABPN1, a Target of p63, Modulates Keratinocyte Differentiation through Regulation of p63α mRNA Translation.
Mohibi S; Zhang J; Chen X
J Invest Dermatol; 2020 Nov; 140(11):2166-2177.e6. PubMed ID: 32243883
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA LUCAT1 promotes the progression of clear cell renal cell carcinoma via the microRNA-375/YAP1 axis.
Wang X; Ou H; Zhou L; Liu H; Liu X; Zhang H
Exp Ther Med; 2021 Jul; 22(1):754. PubMed ID: 34035851
[TBL] [Abstract][Full Text] [Related]
18. ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway.
Xu J; Wang Y; Jiang J; Yin C; Shi B
J Transl Med; 2023 Jan; 21(1):56. PubMed ID: 36717944
[TBL] [Abstract][Full Text] [Related]
19. VHL mutation-mediated SALL4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via Akt/GSK-3β signaling.
Sun J; Tang Q; Gao Y; Zhang W; Zhao Z; Yang F; Hu X; Zhang D; Wang Y; Zhang H; Song B; Zhang B; Wang H
J Exp Clin Cancer Res; 2020 Jun; 39(1):104. PubMed ID: 32513235
[TBL] [Abstract][Full Text] [Related]
20. Loss of nuclear poly(A)-binding protein 1 causes defects in myogenesis and mRNA biogenesis.
Apponi LH; Leung SW; Williams KR; Valentini SR; Corbett AH; Pavlath GK
Hum Mol Genet; 2010 Mar; 19(6):1058-65. PubMed ID: 20035013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
